Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma. [electronic resource] by
- Kumar, Anita
- Vardhana, Santosha
- Moskowitz, Alison J
- Porcu, Pierluigi
- Dogan, Ahmet
- Dubovsky, Jason A
- Matasar, Matthew J
- Zhang, Zhigang
- Younes, Anas
- Horwitz, Steven M
Producer: 20190308
In:
Blood advances vol. 2
Availability: No items available.
|
|
18.
|
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing. [electronic resource] by
- Dubovsky, Jason A
- Chappell, Danielle L
- Harrington, Bonnie K
- Agrawal, Kitty
- Andritsos, Leslie A
- Flynn, Joseph M
- Jones, Jeffrey A
- Paulaitis, Michael E
- Bolon, Brad
- Johnson, Amy J
- Byrd, John C
- Muthusamy, Natarajan
Producer: 20140107
In:
Blood vol. 122
Availability: No items available.
|
|
19.
|
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. [electronic resource] by
- Miklos, David
- Cutler, Corey S
- Arora, Mukta
- Waller, Edmund K
- Jagasia, Madan
- Pusic, Iskra
- Flowers, Mary E
- Logan, Aaron C
- Nakamura, Ryotaro
- Blazar, Bruce R
- Li, Yunfeng
- Chang, Stephen
- Lal, Indu
- Dubovsky, Jason
- James, Danelle F
- Styles, Lori
- Jaglowski, Samantha
Producer: 20171212
In:
Blood vol. 130
Availability: No items available.
|
|
20.
|
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694. [electronic resource] by
- Zhong, Yiming
- Dong, Shuai
- Strattan, Ethan
- Ren, Li
- Butchar, Jonathan P
- Thornton, Kelsey
- Mishra, Anjali
- Porcu, Pierluigi
- Bradshaw, J Michael
- Bisconte, Angelina
- Owens, Timothy D
- Verner, Erik
- Brameld, Ken A
- Funk, Jens Oliver
- Hill, Ronald J
- Johnson, Amy J
- Dubovsky, Jason A
Producer: 20150518
In:
The Journal of biological chemistry vol. 290
Availability: No items available.
|